MAIA Biotechnology Inc. (MAIA)
AMEX: MAIA
· Real-Time Price · USD
1.73
-0.07 (-3.89%)
At close: Oct 03, 2025, 3:59 PM
1.74
0.57%
After-hours: Oct 03, 2025, 07:58 PM EDT
-3.89% (1D)
| Bid | 1.72 |
| Market Cap | 57.08M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -16.17M |
| EPS (ttm) | -0.58 |
| PE Ratio (ttm) | -2.98 |
| Forward PE | -2.6 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.74 |
| Volume | 521,655 |
| Avg. Volume (20D) | 511,096.7 |
| Open | 1.82 |
| Previous Close | 1.80 |
| Day's Range | 1.66 - 1.83 |
| 52-Week Range | 1.40 - 3.48 |
| Beta | 0.03 |
| Ex-Dividend Date | n/a |
About MAIA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAIA
Website n/a
1 month ago
+7.14%
MAIA Biotechnology shares are trading higher after...
Unlock content with
Pro Subscription
2 months ago
+9.24%
MAIA Biotechnology shares are trading higher after the company announced it dosed its first patient in its Taiwan expansion stage of the THIO-101 Phase 2 trial.
